IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 24
- DOI:
- 10.3760/cma.j.issn.0366-6999.2010.24.010
- Key Word:
- stomach neoplasms;IMP3 protein,human;immunohistochemistry;prognosis
Abstract： Background Insulin-like growth factor-Ⅱ mRNA-binding protein 3 (IMP3) is a newly identified mRNA-binding protein that is involved in embryogenesis and carcinogenesis of some malignant tumors. The aim of this study was to detect the expression of IMP3 protein in gastric adenocarcinoma (GAC) and the correlation with clinicopathological features.Methods IMP3 protein in 92 samples of GAC was evaluated by immunohistochemical method. The Mann-Whitney U test and Kruskal-Wallis H test were used to compare IMP3 expression and clinicopathological parameters. Kaplan-Meier survival curve, log-rank test and Cox-regression model were used to evaluate the correlation of IMP3 protein expression to the prognosis of patients.Results Out of 92 cases of adjacent normal mucosa (ANM), 10 with dysplasia demonstrated weak expression of IMP3 and 82 without dysplasia showed negative expression. Out of 92 cases of GAC, positive immunohistochemical stain for IMP3 was identified in 75 (82%) cases. A comparison of IMP3 expression in GAC and ANM showed stronger immunohistochemical reactivity in GAC (P ＜0.05). High expression of IMP3 was found to be associated with lymphoid metastasis, high Ki-67 labelling index, and patient poor outcome (P ＜0.05). There was a significant TNM stage difference between GAC with and without IMP3 expression (P＜0.05). Tumors with higher stage showed higher level of IMP3 expression, In multivariate analysis, IMP3 emerged as an independent predictor of survival.Conclusions Increase of IMP3 expression suggests that IMP3 may play an importent role in the carcinogenesis and tumor metastasis in GAC. It could be regarded as a novel proliferation and prognostic indicator for patients with GAC.
- [1]HUANG Chang-ming,WANG Jia-bin,LU Hui-shan,etc.Prognostic impact of splenectomy on advanced proximal gastric cancer with No.10 lymph node metastasis[J].2009,(22).
- [2]Rock KL,Dresser K,Li C,etc.IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression.[J].2007,20(2).
- [3]Sheinin Y,Hoffmann NE,Leibovich BC,etc.External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma.[J].2008,112(7).
- [4]Eggenschwiler J.,Ludwig T.,Fisher P.,etc.Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel\u00a0syndromes[J].1997.
- [5]F L, Sun,W L, Dean,G, Kelsey,etc.Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome.[J].1997,389(6653).
- [6]Hu Y,Herrick DJ,Brewer G,etc.The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells[J].2005,280(18).
- [7]Yaniv K,Fainsod A,Kalcheim C,etc.The RNA-binding protein Vg1 RBP is required for cell migration during early neural development.[J].2003,130(23).
- [8]Wewer UM. Christiansen J.,Runge S.,Lykke-Andersen J.,etc.H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein[J].2000,275(38).
- [9]Hammer NA,Hansen TV,Byskov AG,etc.Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer[J].2005,130(2).
- [10]T M, Gress,F, Müller-Pillasch,M, Geng,etc.A pancreatic cancer-specific expression profile.[J].1996,13.
- [11]Friederike Mueller-Pillasch,Barbara Pohl,Monika Wilda,etc.Expression of the highly conserved RNA binding protein KOC in embryogenesis[J].1999,88(1).
- [12]Heeson S,Douglas E,Moore GE,etc.An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype.[J].2004,13(2).
- [13]Doyle GA,Betz NA,Leeds PF,etc.The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins.[J].1998,26(22).
- [14]Wewer UM,Jonson L,Nielsen FC,etc.RNA-binding IMPs promote cell adhesion and invadopodia formation.[J].2006,25(7).
- [15]Wang T,Hopkins D,Schmidt C,etc.Identification of genes differentially over-expressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysis.[J].2000,19(12).
- [16]Wewer UM,Lykke Andersen-J,Nielsen J,etc.A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development.[J].1999,19(2).
- [17]Fischer AH,Zota V,Rock KL,etc.Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations.[J].2007,20(12).
- [18]Chen W,Wu CL,Chu PG,etc.Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study.[J].2006,7(7).